- Home
- MRVI vs AII Comparison
MRVI vs AII Comparison
Compare MRVI & AII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- AII
- Stock Information
- Founded
- MRVI 2014
- AII 2006
- Country
- MRVI United States
- AII United States
- Employees
- MRVI N/A
- AII N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- AII Property-Casualty Insurers
- Sector
- MRVI Health Care
- AII Finance
- Exchange
- MRVI Nasdaq
- AII Nasdaq
- Market Cap
- MRVI 371.8M
- AII 370.5M
- IPO Year
- MRVI 2020
- AII 2025
- Fundamental
- Price
- MRVI $2.42
- AII $19.96
- Analyst Decision
- MRVI Hold
- AII Buy
- Analyst Count
- MRVI 10
- AII 4
- Target Price
- MRVI $5.84
- AII $21.67
- AVG Volume (30 Days)
- MRVI 1.4M
- AII 76.2K
- Earning Date
- MRVI 08-11-2025
- AII 08-12-2025
- Dividend Yield
- MRVI N/A
- AII N/A
- EPS Growth
- MRVI N/A
- AII N/A
- EPS
- MRVI N/A
- AII 60.71
- Revenue
- MRVI $219,830,000.00
- AII $260,047,000.00
- Revenue This Year
- MRVI N/A
- AII $25.82
- Revenue Next Year
- MRVI $7.23
- AII $25.78
- P/E Ratio
- MRVI N/A
- AII $0.33
- Revenue Growth
- MRVI N/A
- AII 1.73
- 52 Week Low
- MRVI $1.67
- AII $15.78
- 52 Week High
- MRVI $9.60
- AII $20.30
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- AII N/A
- Support Level
- MRVI $2.28
- AII N/A
- Resistance Level
- MRVI $2.47
- AII N/A
- Average True Range (ATR)
- MRVI 0.14
- AII 0.00
- MACD
- MRVI -0.01
- AII 0.00
- Stochastic Oscillator
- MRVI 27.45
- AII 0.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.